In the final phase of our study, we screened natural product derivatives for active ingredients with potential against HCC and examined whether bufalin could target JAK1 to inhibit hepatoma cell migration and impede the metastasis of HCC. Here, JAK1 is linked to hepatocellular carcinoma.